Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

被引:18
作者
Holyoake, Daniel L. P. [1 ]
Aznar, Marianne [2 ]
Mukherjee, Somnath [1 ,3 ]
Partridge, Mike [1 ]
Hawkins, Maria A. [1 ]
机构
[1] Univ Oxford, Dept Oncol, CRUK MRC Oxford Inst Radiat Oncol, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England
[2] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England
[3] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
基金
英国医学研究理事会;
关键词
Pancreatic cancer; Duodenum; Toxicity; Normal tissue; NTCP; Meta-analysis; UNRESECTABLE PANCREATIC-CANCER; MODULATED RADIATION-THERAPY; NORMAL TISSUE; GASTROINTESTINAL TOXICITY; SMALL-BOWEL; TRIAL; GEMCITABINE; ESCALATION; PREDICTORS; PARAMETERS;
D O I
10.1016/j.radonc.2017.04.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Gastro-intestinal toxicity is dose-limiting in abdominal radiotherapy and correlated with duodenum dose-volume parameters. We aimed to derive updated NTCP model parameters using published data and prospective radiotherapy quality-assured cohort data. Material and methods: A systematic search identified publications providing duodenum dose-volume histogram (DVH) statistics for clinical studies of conventionally-fractionated radiotherapy. Values for the Lyman-Kutcher-Burman (LKB) NTCP model were derived through sum-squared-error minimisation and using leave-one-out cross-validation. Data were corrected for fraction size and weighted according to patient numbers, and the model refined using individual patient DVH data for two further cohorts from prospective clinical trials. Results: Six studies with published DVH data were utilised, and with individual patient data included outcomes for 531 patients in total (median follow-up 16 months). Observed gastro-intestinal toxicity rates ranged from 0% to 14% (median 8%). LKB parameter values for unconstrained fit to published data were: n = 0.070, m = 0.46, TD50(1)) [Gy] = 183.8, while the. values for the model incorporating the individual patient data were n = 0.193, m = 0.51, TD50(1) [Gy] = 299.1. Conclusions: LKB parameters derived using published data are shown to be consistent to those previously obtained using individual patient data, supporting a small volume-effect and dependence on exposure to high threshold dose. (C) 2017 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 123 (2017) 431-437
引用
收藏
页码:431 / 437
页数:7
相关论文
共 39 条
[1]   A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer [J].
Ben-Josef, Edgar ;
Schipper, Mathew ;
Francis, Isaac R. ;
Hadley, Scott ;
Ten-Haken, Randall ;
Lawrence, Theodore ;
Normolle, Daniel ;
Simeone, Diane M. ;
Sonnenday, Christopher ;
Abrams, Ross ;
Leslie, William ;
Khan, Gazala ;
Zalupski, Mark M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05) :1166-1171
[2]   FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION [J].
BURMAN, C ;
KUTCHER, GJ ;
EMAMI, B ;
GOITEIN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :123-135
[3]   Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma [J].
Cattaneo, Giovanni M. ;
Passoni, Paolo ;
Longobardi, Barbara ;
Slim, Najla ;
Reni, Michele ;
Cereda, Stefano ;
di Muzio, Nadia ;
Calandrino, Riccardo .
RADIOTHERAPY AND ONCOLOGY, 2013, 108 (01) :66-71
[4]  
Deore S. M., 1993, Strahlentherapie und Onkologie, V169, P521
[5]   Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial [J].
Dische, S ;
Saunders, MI ;
Sealy, R ;
Werner, ID ;
Verma, N ;
Foy, C ;
Bentzen, SM .
RADIOTHERAPY AND ONCOLOGY, 1999, 53 (02) :93-98
[6]   Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas [J].
Elhammali, Adnan ;
Patel, Mukund ;
Weinberg, Benjamin ;
Verma, Vivek ;
Liu, Jingxia ;
Olsen, Jeffrey R. ;
Gay, Hiram A. .
RADIATION ONCOLOGY, 2015, 10
[7]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[8]   Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial [J].
Fokas, Emmanouil ;
Clifford, Charlotte ;
Spezi, Emiliano ;
Joseph, George ;
Branagan, Jennifer ;
Hurt, Chris ;
Nixon, Lisette ;
Abrams, Ross ;
Staffurth, John ;
Mukherjee, Somnath .
RADIOTHERAPY AND ONCOLOGY, 2015, 117 (03) :432-437
[9]   Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise [J].
Gulliford, Sarah L. ;
Partridge, Mike ;
Sydes, Matthew R. ;
Webb, Steve ;
Evans, Philip M. ;
Dearnaley, David P. .
RADIOTHERAPY AND ONCOLOGY, 2012, 102 (03) :347-351
[10]   GASTROINTESTINAL MORBIDITY OF ADJUVANT RADIOTHERAPY IN STAGE-I MALIGNANT TERATOMA OF THE TESTIS [J].
HAMILTON, CR ;
HORWICH, A ;
BLISS, JM ;
PECKHAM, MJ .
RADIOTHERAPY AND ONCOLOGY, 1987, 10 (02) :85-90